home / stock / adil / adil news

ADIL News and Press, Adial Pharmaceuticals Inc From 02/24/26

Stock Information
Company Name: Adial Pharmaceuticals Inc
Stock Symbol: ADIL
Market: NASDAQ
Website: adialpharma.com
Menu
ADIL ADIL Quote ADIL Short ADIL News ADIL Articles ADIL Message Board
Get ADIL Alerts

News, Short Squeeze, Breakout and More Instantly...
ADIL - Adial Pharmaceuticals Regains Full Compliance with Nasdaq Listing Requirement

GLEN ALLEN, Va., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. ( NASDAQ: ADIL ) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, t...
ADIL - Adial Pharmaceuticals to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference

GLEN ALLEN, Va., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. ( NASDAQ: ADIL ) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, t...

ADIL - Adial Applauds Congressional Directive Advancing Alternative Clinical Trial Endpoints for Substance Use Disorders, Strengthening Regulatory Path for AD04

GLEN ALLEN, Va., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. ( NASDAQ: ADIL ) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, t...

ADIL - Adial Pharmaceuticals announces 1-for-25 reverse stock split; shares down

2026-02-03 16:30:36 ET More on Adial Pharmaceuticals Seeking Alpha’s Quant Rating on Adial Pharmaceuticals Historical earnings data for Adial Pharmaceuticals Financial information for Adial Pharmaceuticals Read the full article on Seeking Alpha ...
ADIL - Adial Pharmaceuticals Announces Reverse Stock Split to Regain Compliance with Nasdaq's Minimum Bid Price Requirement

GLEN ALLEN, Va., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL)  (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorde...

ADIL - Adial Pharmaceuticals Announces Publication of International PCT Patent Application to Protect Core Assets and Extend IP Exclusivity to at least 2045

GLEN ALLEN, Va., Jan. 14, 2026 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. ( NASDAQ: ADIL ) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, a...

ADIL - Adial Pharmaceuticals Announces a Warrant Inducement Transaction for Approximately $2.86 Million in Gross Proceeds

GLEN ALLEN, Va., Nov. 26, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, tod...
ADIL - Adial Pharmaceuticals GAAP EPS of -$0.08

2025-11-14 13:31:19 ET More on Adial Pharmaceuticals Seeking Alpha’s Quant Rating on Adial Pharmaceuticals Historical earnings data for Adial Pharmaceuticals Financial information for Adial Pharmaceuticals Read the full article on Seeking Alpha ...

ADIL - Adial Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update

GLEN ALLEN, Va., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders,...

ADIL - Expected US Company Earnings on Wednesday, November 12th, 2025

RWE AG ADR (RWEOY) is expected to report $0.16 for Q3 2025 Hillenbrand Inc (HI) is expected to report $0.62 for Q4 2025 Ardent Health Inc. (ARDT) is expected to report $0.42 for Q3 2025 Quince Therapeutics Inc. (QNCX) is expected to report $-0.2 for Q3 2025 GlobalFoundries Inc. (G...
Previous 10 Next 10